Published in Infect Immun on April 01, 1989
Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev (1998) 17.27
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev (1998) 5.78
Factors promoting acute and chronic diseases caused by yersiniae. Clin Microbiol Rev (1991) 4.53
LcrD, a membrane-bound regulator of the Yersinia pestis low-calcium response. J Bacteriol (1991) 3.43
Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun (1993) 3.16
Identification and cloning of a hemin storage locus involved in the pigmentation phenotype of Yersinia pestis. J Bacteriol (1990) 3.09
Electron microscopic evidence for in vivo extracellular localization of Yersinia pseudotuberculosis harboring the pYV plasmid. Infect Immun (1990) 2.95
Yops of Yersinia spp. pathogenic for humans. Infect Immun (1993) 2.92
Invasin production by Yersinia pestis is abolished by insertion of an IS200-like element within the inv gene. Infect Immun (1996) 2.64
YopM inhibits platelet aggregation and is necessary for virulence of Yersinia pestis in mice. Infect Immun (1990) 2.53
Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun (1995) 2.43
Yersinia pestis pH 6 antigen: genetic, biochemical, and virulence characterization of a protein involved in the pathogenesis of bubonic plague. Infect Immun (1990) 2.30
The Yersinia pestis V antigen is a regulatory protein necessary for Ca2(+)-dependent growth and maximal expression of low-Ca2+ response virulence genes. J Bacteriol (1991) 2.30
Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect Immun (1994) 2.26
DNA sequencing and analysis of the low-Ca2+-response plasmid pCD1 of Yersinia pestis KIM5. Infect Immun (1998) 2.26
Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect Immun (1995) 2.04
Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells. Infect Immun (1995) 2.02
Differential effects of deletions in lcrV on secretion of V antigen, regulation of the low-Ca2+ response, and virulence of Yersinia pestis. J Bacteriol (1995) 1.93
Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infect Immun (2004) 1.73
Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines (2008) 1.71
Yersinia pestis YopM: thrombin binding and overexpression. Infect Immun (1992) 1.69
The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun (2004) 1.66
Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect Immun (2003) 1.64
The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG. J Bacteriol (1998) 1.60
Structure and regulation of the Yersinia pestis yscBCDEF operon. J Bacteriol (1992) 1.50
Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect Immun (1997) 1.45
Immune defense against pneumonic plague. Immunol Rev (2008) 1.44
Virulence plasmid-encoded YopK is essential for Yersinia pseudotuberculosis to cause systemic infection in mice. Infect Immun (1995) 1.36
Physiological basis of the low calcium response in Yersinia pestis. Infect Immun (1994) 1.31
Humoral and cellular defense against intestinal murine infection with Yersinia enterocolitica. Infect Immun (1991) 1.28
The Yersinia pestis Ail protein mediates binding and Yop delivery to host cells required for plague virulence. Infect Immun (2008) 1.23
Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague. Infect Immun (2006) 1.23
Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis. Infect Immun (2005) 1.19
Yersinia has a tropism for B and T cell zones of lymph nodes that is independent of the type III secretion system. PLoS Pathog (2006) 1.14
The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence. Infect Immun (2010) 1.14
DsbA is required for stable expression of outer membrane protein YscC and for efficient Yop secretion in Yersinia pestis. J Bacteriol (1999) 1.12
Gr1+ cells control growth of YopM-negative yersinia pestis during systemic plague. Infect Immun (2009) 1.12
Three Yersinia pestis adhesins facilitate Yop delivery to eukaryotic cells and contribute to plague virulence. Infect Immun (2010) 1.11
YopK regulates the Yersinia pestis type III secretion system from within host cells. Mol Microbiol (2011) 1.11
IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection. J Immunol (2010) 1.10
Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect Immun (1999) 1.04
Kinetics of innate immune response to Yersinia pestis after intradermal infection in a mouse model. Infect Immun (2012) 1.01
Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP. Infect Immun (2006) 1.01
Regulation of the Yersinia type III secretion system: traffic control. Front Cell Infect Microbiol (2013) 1.00
Absence of inflammation and pneumonia during infection with nonpigmented Yersinia pestis reveals a new role for the pgm locus in pathogenesis. Infect Immun (2009) 1.00
Genome-wide mutant fitness profiling identifies nutritional requirements for optimal growth of Yersinia pestis in deep tissue. MBio (2014) 0.97
D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague. Infect Immun (2009) 0.96
A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis. Infect Immun (2011) 0.96
The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches. Infect Immun (2006) 0.95
The resistance of BALB/cJ mice to Yersinia pestis maps to the major histocompatibility complex of chromosome 17. Infect Immun (2008) 0.95
Interferon consensus sequence binding protein confers resistance against Yersinia enterocolitica. Infect Immun (2000) 0.93
Characterization of three proteins expressed from the virulence region of plasmid pSDL2 in Salmonella dublin. Infect Immun (1991) 0.93
Early apoptosis of macrophages modulated by injection of Yersinia pestis YopK promotes progression of primary pneumonic plague. PLoS Pathog (2013) 0.91
YopK controls both rate and fidelity of Yop translocation. Mol Microbiol (2012) 0.90
The Yersinia pestis YscY protein directly binds YscX, a secreted component of the type III secretion machinery. J Bacteriol (2000) 0.90
ROS-inhibitory activity of YopE is required for full virulence of Yersinia in mice. Cell Microbiol (2010) 0.88
Phosphoglucomutase of Yersinia pestis is required for autoaggregation and polymyxin B resistance. Infect Immun (2009) 0.86
Acute mesenteric lymphadenitis due to Yersinia pseudotuberculosis lacking a virulence plasmid. J Clin Microbiol (1991) 0.85
YopR impacts type III needle polymerization in Yersinia species. Mol Microbiol (2009) 0.83
Contributions of chaperone/usher systems to cell binding, biofilm formation and Yersinia pestis virulence. Microbiology (2010) 0.79
A novel post-exposure medical countermeasure L-97-1 improves survival and acute lung injury following intratracheal infection with Yersinia pestis. Innate Immun (2011) 0.78
Guanylate Binding Proteins regulate inflammasome activation in response to hyper-injected Yersinia translocon components. Infect Immun (2017) 0.76
Yersinia pestis YopK inhibits bacterial adhesion to host cells by binding to the extracellular matrix adaptor protein matrilin-2. Infect Immun (2017) 0.75
Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med (1954) 68.67
Plasmid insertion mutagenesis and lac gene fusion with mini-mu bacteriophage transposons. J Bacteriol (1984) 12.63
Studies on the nutrition and physiology of Pasteurella pestis. VI. A differential plating medium for the estimation of the mutation rate to avirulence. J Bacteriol (1961) 9.14
Virulence genes regulated at the transcriptional level by Ca2+ in Yersinia pestis include structural genes for outer membrane proteins. Infect Immun (1986) 6.92
Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins. Infect Immun (1984) 6.63
The genus Yersinia: biochemistry and genetics of virulence. Curr Top Microbiol Immunol (1972) 6.32
Plasmids in Yersinia pestis. Infect Immun (1981) 6.22
The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague. J Immunol (1959) 5.13
Expression of the temperature-inducible outer membrane proteins of yersiniae. Infect Immun (1985) 4.36
In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae. Infect Immun (1984) 4.16
Genetic analysis of the low calcium response in Yersinia pestis mu d1(Ap lac) insertion mutants. J Bacteriol (1984) 3.90
Genetically manipulated virulence of Yersinia enterocolitica. Infect Immun (1984) 3.81
Vwa+ phenotype of Yersinia enterocolitica. Infect Immun (1983) 3.72
Genetic analysis of virulence plasmid from a serogroup 9 Yersinia enterocolitica strain: role of outer membrane protein P1 in resistance to human serum and autoagglutination. Infect Immun (1985) 2.81
Growth in mouse peritoneal macrophages of Yersinia pestis lacking established virulence determinants. Infect Immun (1984) 2.60
Yersinia pestis grows within phagolysosomes in mouse peritoneal macrophages. Infect Immun (1984) 2.52
Molecular cloning and expression of calcium-regulated, plasmid-coded proteins of Y. pseudotuberculosis. Microb Pathog (1987) 2.45
Plasmid-mediated resistance to phagocytosis in Yersinia enterocolitica. Infect Immun (1987) 2.43
Roles of V antigen in promoting virulence and immunity in yersiniae. J Immunol (1984) 2.32
Localization in Yersinia pestis of peptides associated with virulence. Infect Immun (1982) 2.26
Plasminogen activator/coagulase gene of Yersinia pestis is responsible for degradation of plasmid-encoded outer membrane proteins. Infect Immun (1988) 2.15
Probing the phagolysosomal environment of human macrophages with a Ca2+-responsive operon fusion in Yersinia pestis. Nature (1986) 1.95
Virulence of Pasteurella pestis. Nature (1957) 1.89
Plasmid-determined cytotoxicity in Yersinia pestis and Yersinia pseudotuberculosis. Infect Immun (1986) 1.83
Inhibition of human neutrophil chemiluminescence by plasmid-mediated outer membrane proteins of Yersinia enterocolitica. Infect Immun (1985) 1.72
Roles of V antigen in promoting virulence in Yersiniae. Contrib Microbiol Immunol (1987) 1.70
The initial suppression of bacterial growth in a salmonella infection is mediated by a localized rather than a systemic response. Microb Pathog (1987) 1.60
The plasmid-encoded outer-membrane proteins of Yersinia pestis. Rev Infect Dis (1988) 1.59
Post-translational regulation of Lcr plasmid-mediated peptides in pesticinogenic Yersinia pestis. Microb Pathog (1987) 1.47
Virulence-plasmid is associated with the inhibition of opsonization in Yersinia enterocolitica and Yersinia pseudotuberculosis. Clin Exp Immunol (1987) 1.36
Defect in macrophage effector function confers Salmonella typhimurium susceptibility on C3H/HeJ mice. Cell Immunol (1982) 1.28
Regulation of expression of V antigen and outer membrane proteins in Yersinia pestis. Contrib Microbiol Immunol (1987) 1.26
BIOLOGICAL ACTIVITIES IN EXTRACTS OF PASTEURELLA PESTIS AND THEIR RELATION TO THE "PH 6 ANTIGEN". J Bacteriol (1963) 1.20
Modulation of the low-calcium response in Yersinia pestis via plasmid-plasmid interaction. Microb Pathog (1987) 1.18
Plague toxins. A critical review. Curr Top Microbiol Immunol (1967) 1.16
Chronic infections in laboratory rodents from inoculation of nonencapsulated plague bacilli (Yersinia pestis). Experientia (1983) 0.90
Properties and pharmacological action of plague murine toxin. Pharmacol Ther (1981) 0.87
Adenocarcinoma of renal pelvis. Arch Pathol Lab Med (1993) 1.63
Proliferation of abnormal bone marrow histiocytes, an undesired effect of granulocyte macrophage-colony-stimulating factor therapy in a patient with Hurler's syndrome undergoing bone marrow transplantation. Am J Hematol (1992) 1.39
c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression. Oncogene (2011) 1.15
Intestinal and pulmonary cryptosporidiosis in an infant with severe combined immune deficiency. J Pediatr Gastroenterol Nutr (1984) 1.14
A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. Cancer Res (1999) 1.13
Investigation into the histogenesis of congenital epulis of the newborn. Oral Surg Oral Med Oral Pathol (1993) 1.02
Gastric carcinoma metastatic to the breast. J Surg Oncol (1991) 1.02
Mycosis fungoides: initial diagnosis via palatal biopsy with discussion of diagnostic advantages of plastic embedding. Oral Surg Oral Med Oral Pathol (1984) 0.96
Expression of terminal deoxynucleotidyl transferase in human thymus during ontogeny and development. J Immunol (1983) 0.88
Cutaneous malignant lymphoma: a pathologic study of 50 cases with clinical analysis of 37. Cancer (1981) 0.87
Gleason histologic grading in prostatic carcinoma. Correlation of 18-gauge core biopsy with prostatectomy. Arch Pathol Lab Med (1994) 0.86
Etiologies for non-correlating cervical cytologies and biopsies. Am J Clin Pathol (1995) 0.84
Bone marrow metastases from small cell cancer of the head and neck. Head Neck (1994) 0.84
Ultrastructure of osteoclastoma-like giant cell tumor of thyroid. Am J Surg Pathol (1978) 0.83
Effect of lithium in murine immunodeficiency virus infected animals. Pathobiology (1993) 0.81
Proliferation-related nucleolar antigens P145 and P120 associated with separate nucleolar elements and differences in tissue distribution. Cancer Commun (1989) 0.81
Unusual immunofluorescence patterns for terminal deoxynucleotidyl transferase in blast crisis chronic myelogenous leukemia. Am J Clin Pathol (1981) 0.80
Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma. Arch Pathol Lab Med (1994) 0.80
Lymphangioleiomyomatosis. Am Surg (1993) 0.80
Isolation and characterization of a spontaneously transformed malignant mouse mammary epithelial cell line in culture. Carcinogenesis (1998) 0.79
A new solid-phase immunoassay for terminal deoxynucleotidyl transferase: analysis of TdT antigen in cells, plasma, and serum. Blood (1985) 0.78
Single focus of adenocarcinoma in the prostate biopsy specimen is not predictive of the pathologic stage of disease. Urology (1996) 0.78
Short-term treatment with novel ribonucleotide reductase inhibitors Trimidox and Didox reverses late-stage murine retrovirus-induced lymphoproliferative disease with less bone marrow toxicity than hydroxyurea. Antivir Chem Chemother (2002) 0.78
Evaluation of methods of detecting terminal deoxynucleotidyl transferase in human hematologic malignancies. Comparison of immunofluorescence and enzymatic assays. Am J Clin Pathol (1982) 0.77
PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer types. Cancer Gene Ther (2008) 0.77
Expression of p53 protein in pancreatic adenocarcinoma. Relationship to cigaret smoking. Int J Pancreatol (1995) 0.77
Pseudolymphoma of the stomach. A diagnostic and therapeutic dilemma. Arch Surg (1981) 0.77
Angiotrophic lymphoma. Presentation in uterine vessels with cytogenetic studies. Arch Pathol Lab Med (1990) 0.77
Colony-stimulating factor and macrophage proliferation. Am J Clin Pathol (1994) 0.75
Marked hypodiploidy in blast phase chronic myelogenous leukemia: report of a case and review of the literature. Am J Hematol (1987) 0.75
Incidental discovery at radical mastectomy of inapparent Hodgkin's disease in long term survivors. Cancer (1978) 0.75
Malakoplakia of liver associated with a perforated colonic diverticulum. A case report and review of the literature. J Clin Gastroenterol (1994) 0.75
Immunoblastic lymphadenopathy and adenocarcinoma of the pancreas: a case report. Cancer (1978) 0.75
Role of natural killer cells in the pathogenesis of human acute graft-versus-host disease. Transplantation (1993) 0.75
Case of the month. The Autopsy Committee of the College of American Pathologists. Arch Intern Med (1997) 0.75
Human recombinant interleukin-2 provokes infiltration of lymphocytes into myocardium and liver in rabbits. J Biol Response Mod (1990) 0.75
Proliferating cell nuclear antigen in prostatic adenocarcinoma: correlation with established prognostic indicators. Urology (1994) 0.75
Primary retroperitoneal cysts: report of an unusual case and a survey of the literature. Arch Surg (1982) 0.75
Secondary lymphoma of the thyroid in 99mTc-pertechnetate scintigraphy. Eur J Nucl Med (1987) 0.75
Human immunodeficiency virus as a possible cofactor in the development of fulminant hepatitis B in intravenous drug abusers. J Med (1988) 0.75
Skin contraction with pulsed CO2 and erbium:YAG laser. Plast Reconstr Surg (1999) 0.75
Resolution of Ga-67 citrate uptake in the left neck mass of Hodgkin's disease and reversion of double scoliosis of cervical-thoracic and lower lumbar vertebrae. Ann Nucl Med (2000) 0.75